当免疫系统两次攻击时:与SLE相关的肺动脉高血压:一个病例报告
Anaïs Carlier1, Vanessa Smith2, Michel De Pauw3
1Medical Student, Ghent University, Sint-Pietersnieuwstraat 33, Ghent 9000, Belgium.
European heart journal. Case reports
|December 11, 2025
概括
系统性狼与红血球相关的肺动脉高血压 (SLE-PAH) 爆发可以通过持续的免疫抑制来预防. 暂停治疗可能会引发严重的PAH发作,这突显了持续治疗管理这种疾病的重要性.
科学领域:
- 类风湿病学 类风湿病学
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
背景情况:
- 肺动脉高血压 (PAH) 是连接组织疾病 (CTD) 的严重并发症,特别是系统性红斑狼 (SLE).
- 与其他PAH亚型不同,与SLE相关的PAH (SLE-PAH) 具有免疫介导的病理生理学,这表明它在免疫抑制中发挥作用.
- 由于其潜在的自身免疫基础,SLE-PAH的管理需要一种独特的方法.
研究的目的:
- 在患有全身性红斑狼 (SLE) 的患者中报告复发性严重肺动脉高血压 (PAH) 爆发的病例.
- 调查免疫抑制撤销和重新引入对SLE-PAH恶化的影响.
- 突出PAH患者特定心血管药物相关的潜在治疗风险.
主要方法:
- 病例报告详细介绍了一名43岁的女性患者,患有SLE和复发性PAH爆发.
- 在停止和恢复维持性免疫抑制疗法后临床过程的分析.
- 对治疗干预措施的审查,包括皮质类固醇,肺血管扩展剂和心血管药物.
主要成果:
- 在患者停止维持性免疫抑制治疗后,发生了两次严重的PAH爆发.
- 第一次爆发需要用皮质类固醇和肺血管扩张剂进行治疗,并因服用β-阻断剂而引起的循环休克而复杂化.
- 第二次爆发仅通过免疫抑制疗法有效地消失,表明对免疫调节的积极反应.
结论:
- 持续的免疫抑制疗法可能对预防SLE患者的PAH爆发至关重要.
- SLE-PAH表现出对免疫抑制的反应,与其他形式的PAH形成鲜明对比.
- β抑制剂可以在PAH患者中导致危及生命的血液动力学休克,这强调了需要仔细选择药物.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
536
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
536
Autoimmune Disorders
1.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.4K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Other Pulmonary Disorders
1.5K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.5K


